CD8A and cancer: In tumors, cancer cells inhibit the activation of CD8+ T cells (cytotoxic T lymphocytes, CTL) by binding inhibitory checkpoints on the CTL surface such as PD-L1, which is believed to be a critical form of cancer cell immune escape (39).